ClinicalTrials.gov · NCT07220473 · Recruiting
Tirzepatide to Slow Biological Aging
Registry record
NCT07220473 on ClinicalTrials.gov. The registry's last update to this record was 24 March 2026.
Verification record
5 checked · 0 company says · 0 reported · 0 not found · 0 not yet checked
- Title as registered Tirzepatide to Slow Biological Aging Checked Source clinicaltrials.gov Brief title as registered. Checked
- Sponsor The University of Texas Medical Branch, Galveston Checked Source clinicaltrials.gov Lead sponsor as registered. Checked
- Intervention Zepbound Checked Source clinicaltrials.gov Intervention names as registered. Checked
- Primary outcome as registered Change in DNA Methylation-Based Biological Age Checked Source clinicaltrials.gov Primary outcome measure(s) as registered. Checked
- Status Recruiting Checked Source clinicaltrials.gov Overall status as registered; registry last update 2026-03-24. Checked
Check history: NCT07220473 was last read on the registry on November 14, 2026. No earlier checks are recorded. How records are checked.
Corrections: none recorded for this trial. To ask for one, write to [email protected] with the registry number; every correction is checked against the registry record before the record changes.
As registered
- Sponsor: The University of Texas Medical Branch, Galveston
- Phase: Phase 2
- Status: Recruiting
- Intervention: Zepbound
- Primary outcome: Change in DNA Methylation-Based Biological Age
- Countries: United States
- Start: 27 February 2026
- Completion (estimated): January 2028
Results
No results were posted on the registry on the date checked. The Atlas does not summarize findings.